SCHEMBL7003602

SCHEMBL7003602

[CH2]C(N)Sc1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.51
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
BACE1 P56817 1/20 0.40
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2A6 P11509 4/20 0.37
CYP1A2 P05177 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
ANPEP P15144 1/20 0.36
HAO1 Q9UJM8 1/20 0.36
MAP2K2 P36507 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243544 0.76 EPHX1 (0.57) EPHX1ALDH1A1CYP3A4HSD17B10HTR2A
SCHEMBL8779782 0.74 EPHX1 (0.50) EPHX1ALDH1A1CYP3A4HSD17B10BACE1
SCHEMBL5272958 0.74 EPHX1 (0.59) EPHX1ALDH1A1CYP3A4HSD17B10HTR2A
SCHEMBL30484476 0.71 EPHX1 (0.47) EPHX1ALDH1A1CYP3A4HSD17B10BACE1
SCHEMBL22446622 0.71 EPHX1 (0.56) EPHX1ALDH1A1CYP3A4HSD17B10HTR2A
SCHEMBL4640609 0.71 EPHX1 (0.61) EPHX1CYP3A4HTR2AHTR2CHTR2B
SCHEMBL32662877 0.71 EPHX1 (0.61) EPHX1CYP3A4HTR2AHTR2CHTR2B
SCHEMBL30484473 0.71 EPHX1 (0.47) EPHX1ALDH1A1CYP3A4HSD17B10BACE1
SCHEMBL1747933 0.70 CYP2A6 (0.44) EPHX1ALDH1A1CYP3A4HSD17B10LMNA
SCHEMBL6245756 0.70 ALDH1A1 (0.50) EPHX1ALDH1A1CYP3A4HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1340744-A2 Hiv protease inhibitors Agouron Pharmaceuticals, Inc. (US) 2003-09-03 EP disclosed
WO-1995009843-A1 HIV PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1995-04-13 WO disclosed